Novavax Inc (NVAX) is a publicly traded Healthcare sector company. As of August 19, 2026, NVAX trades at $7.94 with a market cap of $1.33B and a P/E ratio of -5.19. NVAX moved -1.55% today. Year to date, NVAX is +18.01%; over the trailing twelve months it is -18.33%. Its 52-week range spans $5.01 to $11.97. Analyst consensus is neutral with an average price target of $13.25. Rallies surfaces NVAX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks NVAX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $7.94 |
| Market Cap | $1.33B |
| P/E Ratio | -5.19 |
| EPS | $-1.52 |
| Dividend Yield | 0.11% |
| 52-Week High | $11.97 |
| 52-Week Low | $5.01 |
| Volume | 1.50M |
| Avg Volume | 0 |
| Revenue (TTM) | $413.80M |
| Net Income | $-247.73M |
| Gross Margin | 78.60% |
4 analysts cover NVAX: 0 strong buy, 2 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $13.25.